NTRK1 and neoplasm: Eph receptors, the largest family of receptor tyrosine kinases, and their ephrin ligands not only regulate many physiological processes in the development of organs, but also have been implicated in numerous pathologies, including tumor progression.6, 7 Among these Eph receptors, EphA7 receptor has attracted growing attention in tumor research.